Professor Aviv Regev, PhD, is Executive Vice President and Global Head of Genentech Research and Early Development at the biotechnology company Genentech, a member of the Roche Group. Prior to Genentech, Regev served as founding director of the Klarman Cell Observatory at the Broad Institute, Professor of Biology at MIT, and Investigator of the Howard Hughes Medical Institute. She is a founding co-chair of the Human Cell Atlas. Aviv Regev has pioneered the development of foundational experimental and computational methods in single-cell genomics and is a leader in deciphering molecular circuits that govern cells, tissues, and organs in health and disease. Among many honors, she is an elected member of the National Academy of Sciences and the National Academy of Medicine in the United States.
For her outstanding research, Prof. Aviv Regev, PhD, is awarded the 2021 Ernst Schering Prize. A seven-member jury composed of international scientists selected Regev’s research from among 27 nominations.
Aviv Regev was nominated for the Ernst Schering Prize by Professor Geneviève Almouzni, PhD, Honorary Director and Head of the Chromatin Dynamics team at the Research Center of the Institut Curie, Paris. Geneviève Almouzni, who will lead a conversation with Aviv Regev about her research at the award ceremony, said: “Aviv Regev is one of the leading scientists of her generation. Her energy and her curiosity are infectious, and she inspires younger generations thanks to her leadership and mentoring skills. Her contributions to the field of single-cell genomics, including the establishment and inspiration of the international Human Cell Atlas community, make her an ideal choice for the Ernst Schering Prize.”
September 08, 2021
Aviv Regev
Schulfarm Insel Scharfenberg, Berlin-Tegel (not open to the public)
Unter den Linden 32-34
10117 Berlin
Telefon: +49.30.20 62 29 62
Email: info@scheringstiftung.de
Thursday to Monday: 1 pm - 7 pm
Saturday to Sunday: 11 am - 7 pm
free entrance